We further showed that our LEP-derived aging signature was enriched in women who had received chemotherapy and those with increased risk of developing breast cancer, lending further support to earlier findings of accelerated aging phenotypes in these groups (Shalabi et al., 2021; Siddique et al., 2021). The gene discussed is LEP; the disease is breast carcinoma.